Cargando…
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer
BACKGROUND: A current critical need remains in the identification of prognostic and predictive markers in early breast cancer. It appears that a distinctive trait of cancer cells is their addiction to hyperactivation of ribosome biogenesis. Thus, ribosome biogenesis might be an innovative source of...
Autores principales: | Nguyen Van Long, Flora, Lardy-Cleaud, Audrey, Carène, Dimitri, Rossoni, Caroline, Catez, Frédéric, Rollet, Paul, Pion, Nathalie, Monchiet, Déborah, Dolbeau, Agathe, Martin, Marjorie, Simioni, Valentin, Bray, Susan, Le Beherec, Doris, Mosele, Fernanda, Bouakka, Ibrahim, Colombe-Vermorel, Amélie, Odeyer, Laetitia, Diot, Alexandra, Jordan, Lee B., Thompson, Alastair M., Jamen, Françoise, Dubois, Thierry, Chabaud, Sylvie, Michiels, Stefan, Treilleux, Isabelle, Bourdon, Jean-Christophe, Pérol, David, Puisieux, Alain, André, Fabrice, Diaz, Jean-Jacques, Marcel, Virginie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092774/ https://www.ncbi.nlm.nih.gov/pubmed/35545761 http://dx.doi.org/10.1186/s12885-022-09552-x |
Ejemplares similares
-
Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes
por: Nguyen Van Long, Flora, et al.
Publicado: (2018) -
p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer
por: Marcel, Virginie, et al.
Publicado: (2013) -
Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group
por: Mourksi, Nour‐El‐Houda, et al.
Publicado: (2022) -
Fibrillarin antibodies in systemic sclerosis
por: Lee, Adrian
Publicado: (2021) -
Current research on viral proteins that interact with fibrillarin
por: Decle-Carrasco, Stefano, et al.
Publicado: (2023)